Group Calls For Classification Clarity Before Clinical-Decision Support Guidance
This article was originally published in The Gray Sheet
Executive Summary
The Clinical Device Support (CDS) Coalition wrote to top FDA officials recently asking the agency to provide clarification on how it wants to classify CDS applications through a "master plan." The industry group says the current de novo process used for such software is creating confusion, burdens and barriers to new applications coming to market.